206 related articles for article (PubMed ID: 21933858)
1. Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation.
Berger MD; Gerber B; Arn K; Senn O; Schanz U; Stussi G
Haematologica; 2012 Jan; 97(1):116-22. PubMed ID: 21933858
[TBL] [Abstract][Full Text] [Related]
2. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program.
Leahy MF; Trentino KM; May C; Swain SG; Chuah H; Farmer SL
Transfusion; 2017 Sep; 57(9):2189-2196. PubMed ID: 28671296
[TBL] [Abstract][Full Text] [Related]
3. Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial.
Chantepie SP; Mear JB; Guittet L; Dervaux B; Marolleau JP; Jardin F; Dutheil JJ; Parienti JJ; Vilque JP; Reman O
Trials; 2015 Nov; 16():533. PubMed ID: 26592377
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
5. Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignancies.
Bowman Z; Fei N; Ahn J; Wen S; Cumpston A; Shah N; Craig M; Perrotta PL; Kanate AS
Eur J Haematol; 2019 May; 102(5):383-388. PubMed ID: 30664281
[TBL] [Abstract][Full Text] [Related]
6. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D
J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994
[TBL] [Abstract][Full Text] [Related]
7. Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial.
Chantepie SP; Mear JB; Briant AR; Vilque JP; Gac AC; Cheze S; Girault S; Turlure P; Marolleau JP; Lebon D; Charbonnier A; Jardin F; Lenain P; Peyro-Saint-Paul L; Abonnet V; Dutheil JJ; Chene Y; Bazin A; Reman O; Parienti JJ
Leuk Res; 2023 Jun; 129():107058. PubMed ID: 37080000
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with transfusion requirements during treatment for acute myelogenous leukemia.
Favre G; Fopp M; Gmür J; Tichelli A; Fey MF; Tobler A; Schatzmann E; Gratwohl A
Ann Hematol; 1993 Oct; 67(4):153-60. PubMed ID: 8218536
[TBL] [Abstract][Full Text] [Related]
9. Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
Lamarche MC; Hammond DE; Hopman WM; Sirosky-Yanyk A; Shepherd L; Bhella SD
Transfusion; 2019 Jul; 59(7):2308-2315. PubMed ID: 31059586
[TBL] [Abstract][Full Text] [Related]
10. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
12. Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.
Evers D; Zwaginga JJ; Tijmensen J; Middelburg RA; de Haas M; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; van der Bom JG
Haematologica; 2017 Jan; 102(1):52-59. PubMed ID: 27634204
[TBL] [Abstract][Full Text] [Related]
13. Comparing the ratio of mean red blood cell transfusion episode rate of 1 unit versus 2 units in hematopoietic stem cell transplant patients.
Avdić A; Tucker S; Evans R; Smith A; Zimmerman MB
Transfusion; 2016 Sep; 56(9):2346-51. PubMed ID: 27481696
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion in hematologic intensive care unit.
Chantepie SP; Mear JB; Parienti JJ; Bazin A; Benabed K; Cheze S; Gac AC; Johnson-Ansah H; Macro M; Cabrera Q; Reboursiere E; Lancesseur C; Damaj G; Reman O
Transfusion; 2017 Feb; 57(2):296-302. PubMed ID: 27861958
[TBL] [Abstract][Full Text] [Related]
15. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
16. Single-unit vs multiple-unit transfusion in hemodynamically stable postpartum anemia: a pragmatic randomized controlled trial.
Hamm RF; Perelman S; Wang EY; Levine LD; Srinivas SK
Am J Obstet Gynecol; 2021 Jan; 224(1):84.e1-84.e7. PubMed ID: 32652065
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
18. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.
Vande Vusse LK; Madtes DK; Guthrie KA; Gernsheimer TB; Curtis JR; Watkins TR
Transfusion; 2014 Apr; 54(4):1071-80. PubMed ID: 24033082
[TBL] [Abstract][Full Text] [Related]
19. [The importance of quality of whole blood and erythrocyte concentrates for autologous transfusion. A literature survey and meta-analysis of in vivo erythrocyte recovery].
Karger R; Kretschmer V
Anaesthesist; 1996 Aug; 45(8):694-707. PubMed ID: 8967582
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia.
Jansen AJ; Caljouw MA; Hop WC; van Rhenen DJ; Schipperus MR
Transfus Med; 2004 Feb; 14(1):33-8. PubMed ID: 15043591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
